Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1621 to 1635 of 7707 results

  1. Lead-I ECG devices for detecting symptomatic atrial fibrillation using single time point testing in primary care (DG35)

    Evidence-based recommendations on lead-I electrocardiogram (ECG) devices (imPulse, Kardia Mobile, MyDiagnostick and Zenicor-ECG) for detecting symptomatic

    Diagnostics guidance
    Published
    8 May 2019
    View recommendations

    Sections for DG35

  2. Therapeutic monitoring of TNF-alpha inhibitors in rheumatoid arthritis (DG36)

    Evidence-based recommendations on enzyme-linked immunosorbent assay (ELISA) tests for therapeutic monitoring of tumour necrosis factor (TNF)-alpha inhibitors in

    Diagnostics guidance
    Published
    10 July 2019
    View recommendations

    Sections for DG36

  3. Point-of-care creatinine devices to assess kidney function before CT imaging with intravenous contrast (DG37)

    Evidence-based recommendations on point-of-care creatinine devices to assess kidney function before CT imaging with intravenous contrast. The tests are

    Diagnostics guidance
    Published
    13 November 2019
    View recommendations

    Sections for DG37

  4. Testing strategies for Lynch syndrome in people with endometrial cancer (DG42)

    Evidence-based recommendations on testing strategies for Lynch syndrome for people with endometrial cancer

    Diagnostics guidance
    Published
    28 October 2020
    View recommendations

    Sections for DG42

  5. SeHCAT (tauroselcholic [75 selenium] acid) for diagnosing bile acid diarrhoea (DG44)

    Evidence-based recommendations on SeHCAT (tauroselcholic [75 selenium] acid) for diagnosing bile acid diarrhoea

    Diagnostics guidance
    Published
    17 November 2021
    View recommendations

    Sections for DG44

  6. PredictSURE IBD and IBDX to guide treatment of Crohn's disease (DG45)

    Evidence-based recommendations on PredictSURE IBD and IBDX for guiding treatment of Crohn’s disease

    Diagnostics guidance
    Published
    23 February 2022
    View recommendations

    Sections for DG45

  7. EarlyCDT Lung for assessing risk of lung cancer in solid lung nodules (DG46)

    Evidence-based recommendations on EarlyCDT Lung for assessing the risk of lung cancer in solid lung nodules

    Diagnostics guidance
    Published
    23 February 2022
    View recommendations

    Sections for DG46

  8. FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist care (DG48)

    Evidence-based recommendations on FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist care

    Diagnostics guidance
    Published
    7 June 2023
    View recommendations

    Sections for DG48

  9. PLGF-based testing to help diagnose suspected preterm pre-eclampsia (DG49)

    Evidence-based recommendations on placental growth factor (PLGF)-based testing to help diagnose suspected preterm pre-eclampsia. The tests are: DELFIA Xpress PLGF 1 2 3, DELFIA Xpress sFlt 1/PLGF 1 2 3 ratio, Elecsys immunoassay sFlt 1/PLGF ratio, Triage PLGF Test

    Diagnostics guidance
    Published
    27 July 2022
    View recommendations

    Sections for DG49

  10. PneuX to prevent ventilator-associated pneumonia (MTG48)

    Evidence-based recommendations on PneuX to prevent ventilator-associated pneumonia.

    Medical technologies guidance
    Published
    8 April 2020
    View recommendations

    Sections for MTG48

  11. Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia (MTG49)

    Evidence-based recommendations on Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia.

    Medical technologies guidance
    Published
    24 June 2020
    View recommendations

    Sections for MTG49

  12. Axonics sacral neuromodulation system for treating refractory overactive bladder (MTG50)

    Evidence-based recommendations on Axonics sacral neuromodulation system for treating refractory overactive bladder.

    Medical technologies guidance
    Published
    3 September 2020
    View recommendations

    Sections for MTG50

  13. SEM Scanner 200 for preventing pressure ulcers (MTG51)

    Evidence-based recommendations on SEM Scanner 200 for preventing pressure ulcers.

    Medical technologies guidance
    Published
    14 October 2020
    View recommendations

    Sections for MTG51

  14. Zio XT for detecting cardiac arrhythmias (MTG52)

    Evidence-based recommendations on Zio XT for detecting cardiac arrhythmias.

    Medical technologies guidance
    Published
    1 December 2020
    View recommendations

    Sections for MTG52

  15. Synergo for non-muscle-invasive bladder cancer (MTG61)

    Evidence-based recommendations on Synergo for non-muscle-invasive bladder cancer.

    Medical technologies guidance
    Published
    30 November 2021
    View recommendations

    Sections for MTG61